Assignee
VOR BIOPHARMA INC
US·12 granted patents·33 pending applications·35 citations·filing 2018–2025
Top patents by PatentIndex Score
45 records- 0196US11571445B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2021·Granted Feb 7, 2023·4 cites·21 claims
- 0296US11559551B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2021·Granted Jan 24, 2023·5 cites·18 claims
- 0396US11382932B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2021·Granted Jul 12, 2022·4 cites·25 claims
- 0496US10925902B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2019·Granted Feb 23, 2021·8 cites·19 claims
- 0595US11903973B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2021·Granted Feb 20, 2024·3 cites·31 claims
- 0695US11464807B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2021·Granted Oct 11, 2022·5 cites·22 claims
- 0793US11389485B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2019·Granted Jul 19, 2022·4 cites·20 claims
- 0882US2024408168A1Compositions and methods for the depletion of cellsVOR BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0981US11975029B2Compositions and methods for inhibition of lineage specific proteinsVOR BIOPHARMA INC·Filed 2018·Granted May 7, 2024·1 cites·19 claims
- 1081US2023053285A1Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1180US12403200B2Methods and compositions for treating autoimmune diseasesVOR BIOPHARMA INC·Filed 2021·Granted Sep 2, 2025·1 cites·24 claims
- 1276US12209135B2Anti-CD45 antibodies and conjugates thereofVOR BIOPHARMA INC·Filed 2024·Granted Jan 28, 2025·0 cites·22 claims
- 1375US2024350550A1Compositions and methods for inhibition of lineage specific proteinsVOR BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1473US12251403B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2020·Granted Mar 18, 2025·0 cites·18 claims
- 1571US2025140342A1Genotyping cells using single-cell dna sequencing dataVOR BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1667US2025295695A1Compositions and methods for mediating epitope engineeringVOR BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1765US2026069706A1Methods for treating autoimmune diseasesVOR BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 1861US2026009051A1Compositions and methods for artificial protospacer adjacent motif (pam) generationVOR BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1960US2025179531A1Compositions and methods for homology-directed repair gene modificationVOR BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2058US2025333515A1Binding agents and methods of use thereofVOR BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2157US2024344058A1Compositions and methods for bcma modificationVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2257US2023364146A1Compositions and methods for cd30 gene modificationVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2357US2023398219A1Compositions and methods for cd38 modificationVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2457US2024033290A1Compositions and methods for cd7 modificationVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2557US2026014202A1Therapeutic methods using antibody drug conjugates (adcs)VOR BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 2657US2024041932A1Compositions and methods for cd5 modificationVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2756US2024238344A1Compositions and methods for cd123 modificationVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2856US2024000846A1Compositions and methods for treating hematopoietic malignancyVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2956US2025122534A1Compositions and methods for gene modificationVOR BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3055US2024110189A1Compositions and methods for cll1 modificationVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 3155US2024408234A1Compositions and methods for multiplex base editing in hematopoietic cellsVOR BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3254US2024417755A1Fusion polypeptides for genetic editing and methods of use thereofVOR BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3354US2022290160A1Compositions and methods for cll1 modificationVOR BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 3453US12291576B2Anti-CD45 antibodies and conjugates thereofVOR BIOPHARMA INC·Filed 2021·Granted May 6, 2025·0 cites·26 claims
- 3552US2024384304A1Inhibitor oligonucleotides and methods of use thereofVOR BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3652US2024352481A1Nfat-responsive reporter systems for assessing chimeric antigen receptor activation and methods of making and using the sameVOR BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3752US2025082755A1Chimeric antigen receptors for treatment of cancerVOR BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3851US2022333116A1Compositions and methods for cd123 modificationVOR BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 3949US2022228153A1Compositions and methods for cd33 modificationVOR BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 4048US2023414755A1Methods and compositions relating to genetically engineered cells expressing chimeric antigen receptorsVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4148US2023364137A1Chimeric antigen receptor expression systemsVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4243US2024200059A1Photocleavable guide rnas and methods of use thereofVOR BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 4339US2024366675A1Compositions and methods for cd34 gene modificationVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4436US2023365675A1Single domain antibodies against cd33VOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4536US2023372484A1Chimeric antigen receptors for treatment of cancerVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VOR BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →